ADAR1 Capital Management »

Erasca shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Erasca (ERAS) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Erasca

Tip: Access up to 7 years of quarterly data

All positions including Erasca held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Erasca by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $162k 10k 16.18
2024-06-30 $7.3k 3.1k 2.36

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Terns Pharmaceuticals Call Option (TERN)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Cytokinetics Com New (CYTK)
Crinetics Pharmaceuticals In (CRNX)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Denali Therapeutics (DNLI)
Beam Therapeutics (BEAM)
Zai Lab Adr (ZLAB)
Septerna (SEPN)
Vir Biotechnology (VIR)
Dbv Technologies S A Sponsored Ads (DBVT)

View all positions for ADAR1 Capital Management

Top funds holding Erasca

Frazier Life Sciences Management
BlackRock
VR Adviser
T. Rowe Price Investment Management
Vanguard Group
Vivo Capital
Vanguard Capital Management
Logos Global Management
Paradigm Biocapital Advisors
Siren
Arch Venture Corp
State Street Corporation
Geode Capital Management
Cormorant Asset Management
Balyasny Asset Management

View all funds holding Erasca